Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04347993 · ClinicalTrials.gov registry record
A Prospective "Universal" Observational Database for COVID-19
A clinical trial, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 4,588
- Enrollment target
NCT04347993: Completed study, sponsored by Hackensack Meridian Health.
NCT04347993 is a clinical trial that has completed, run by Hackensack Meridian Health. The registered enrollment target is 4,588 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04347993 has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 4,588 participants
- Enrollment target
Study Summary
The Hackensack Meridian Health Universal Observational COVID-19, a descriptive observational database, is a multi-center initiative collecting data throughout the Hackensack Meridian Health Network (HMH). HMH utilizes the EPIC system at most of the facilities, which will serve as the primary data source. The database will be designed within the REDCap system. A de-identified dataset will be sent to COTA for primary statistical analysis as requested by the research teams.
Primary Outcome
Number of Participants needing hospitalization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,588 participants |
| Start Date | 2020-03-27 |
| Est. Completion | 2023-06-12 |
What the finished NCT04347993 record still lists
NCT04347993 is an observational study that tracks outcomes without assigning an intervention. Its 4,588 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04347993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04347993 about?
NCT04347993 is a clinical study titled "A Prospective "Universal" Observational Database for COVID-19". The Hackensack Meridian Health Universal Observational COVID-19, a descriptive observational database, is a multi-center initiative collecting data throughout the Hackensack Meridian Health Network (HMH). HMH utilizes the EPIC system at most of the facilities, which will serve as the primary data so...
What is the current status of trial NCT04347993?
This trial is currently completed. The enrollment target is 4,588 participants. The study started on 2020-03-27. Estimated completion is 2023-06-12.
Who is sponsoring clinical trial NCT04347993?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05768217 · 4,600 participants · NA
Community Resiliency Collective Efficacy Intervention
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- NCT06702878 · 4,514 participants · Phase 3
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI